X-Message-Number: 25366
From: "Joe Waynick" <>
Subject: Alcor Delivers Williams' Documents
Date: Mon, 20 Dec 2004 12:40:39 -0700

FOR IMMEDIATE RELEASE                                      For more
information, contact: 

Cheryl Walsh, 602-957-9779



Alcor Life Extension Foundation Delivers Williams' Documents

PHOENIX, Ariz. (December 20, 2004).Joe Waynick, Chief Executive Officer of
Alcor Life Extension Foundation announced today that the Foundation has
delivered all documents pertaining to Ted Williams, in accordance with a
recent order of a Maricopa Superior Court, to the plaintiffs, Ted and Sam
Williams. The final order of the Court was handed down on November 30 and,
according to Waynick, the Foundation met with legal counsel to assess its
options, ultimately deciding not to appeal the Court's decision.

    "Alcor is dedicated to preserving the confidentiality of our patients if
they so request, or if requested by family members," said Waynick.  "Our
goal in this matter was to respect the wishes of Mr. Williams, his children,
and his personal representative.  We realize, however, that the publicity
associated with this case has already affected the privacy wishes of the
family such that we now believe the family will not be able to enjoy privacy
again until the documents are released and the matter put to rest."

    Waynick stressed that the Court's decision applies only to the Williams
matter and the Foundation will continue to work to protect the privacy
concerns of its members and their families.

About Alcor Life Extension Inc.

    The Alcor Life Extension Foundation, a nonprofit organization founded in
1972, is the world leader in cryonics, and cryonics research and technology.
Cryonics is the science of using ultra-cold temperatures to suspend and
preserve human life.  The intent is that technologically advanced scientific
procedures will one day be available to revive cryopreserved humans and
restore them to good health.

    The promise of cryopreservation has taken a quantum leap forward with
the ongoing development of molecular nanotechnology and the introduction of
vitrification to Alcor's protocols.

    One use of nanotechnology is the expectation that cell-sized machines
will be developed to repair damage or cure disease at the cellular level,
including any potential damage that results from the cryopreservation

    Alcor performed its first human cryopreservation in 1976. Since then,
Alcor has engaged in long-term patient care as well as cryopreservation
procedures. Among Alcor's scientific achievements is the use of advanced
cryoprotectant formulas capable of achieving ice-free preservation, known as

    Today, Alcor is the only full-service cryonics organization in
existence.  Alcor has more than 697 members from around the world and 67
patients in cryostasis.  For more information about Alcor and cryonics,
visit www.alcor.org <http://www.alcor.org/> .



 Content-Type: text/html;


Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=25366